554 related articles for article (PubMed ID: 34526087)
101. Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis
Janssen NAF; Nyga R; Vanderbeke L; Jacobs C; Ergün M; Buil JB; van Dijk K; Altenburg J; Bouman CSC; van der Spoel HI; Rijnders BJA; Dunbar A; Schouten JA; Lagrou K; Bourgeois M; Reynders M; van Regenmortel N; Rutsaert L; Lormans P; Feys S; Debavaye Y; Tamion F; Costa D; Maizel J; Dupont H; Chouaki T; Nseir S; Sendid B; Brüggemann RJM; van de Veerdonk FL; Wauters J; Verweij PE
Emerg Infect Dis; 2021 Nov; 27(11):2892-2898. PubMed ID: 34519638
[TBL] [Abstract][Full Text] [Related]
102. Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.
Ogawa Y; Murata K; Hasegawa K; Nishida K; Gohma I; Kasahara K
J Infect Chemother; 2023 Mar; 29(3):239-243. PubMed ID: 36379404
[TBL] [Abstract][Full Text] [Related]
103. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.
Arastehfar A; Carvalho A; van de Veerdonk FL; Jenks JD; Koehler P; Krause R; Cornely OA; S Perlin D; Lass-Flörl C; Hoenigl M
J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32599813
[TBL] [Abstract][Full Text] [Related]
104. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
Lackner N; Thomé C; Öfner D; Joannidis M; Mayerhöfer T; Arora R; Samardzic E; Posch W; Breitkopf R; Lass-Flörl C
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205848
[TBL] [Abstract][Full Text] [Related]
105. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
[TBL] [Abstract][Full Text] [Related]
106. COVID-19-Associated Pulmonary Fungal Infection among Pediatric Cancer Patients, a Single Center Experience.
Madney Y; Shalaby L; Hammad M; Elanany M; Hassan R; Youssef A; Abdo I; Zaki A; Khedr R
J Fungi (Basel); 2022 Aug; 8(8):. PubMed ID: 36012838
[TBL] [Abstract][Full Text] [Related]
107. Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case-Control Study.
Calderón-Parra J; Moreno-Torres V; Mills-Sanchez P; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A
J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205914
[No Abstract] [Full Text] [Related]
108. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
[No Abstract] [Full Text] [Related]
109. COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital.
Ranhel D; Ribeiro A; Batista J; Pessanha M; Cristovam E; Duarte A; Dias A; Coelho L; Monteiro F; Freire P; Veríssimo C; Sabino R; Toscano C
J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682302
[TBL] [Abstract][Full Text] [Related]
110. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
[TBL] [Abstract][Full Text] [Related]
111. Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis.
Beltrame A; Stevens DA; Haiduven D
J Fungi (Basel); 2023 Jun; 9(6):. PubMed ID: 37367625
[TBL] [Abstract][Full Text] [Related]
112. Covid-19 associated pulmonary aspergillosis with extensive cavitary pneumonia: A case report.
Hanif S; Iqbal M; Sethi SM
J Pak Med Assoc; 2023 Jan; 73(1):174-176. PubMed ID: 36842034
[TBL] [Abstract][Full Text] [Related]
113. Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia.
Estella Á; Recuerda Núñez M; Lagares C; Gracia Romero M; Torres E; Alados Arboledas JC; Antón Escors Á; González García C; Sandar Núñez D; López Prieto D; Sánchez Calvo JM
J Fungi (Basel); 2023 Feb; 9(3):. PubMed ID: 36983456
[TBL] [Abstract][Full Text] [Related]
114. Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients.
Shah M; Reveles K; Moote R; Hand E; Kellogg Iii D; Attridge RL; Maselli DJ; Gutierrez GC
Open Forum Infect Dis; 2023 Mar; 10(3):ofad062. PubMed ID: 36879627
[TBL] [Abstract][Full Text] [Related]
115. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
116. Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis.
Román-Montes CM; Bojorges-Aguilar S; Díaz-Lomelí P; Cervantes-Sánchez A; Rangel-Cordero A; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-León A; González-Lara MF
Front Fungal Biol; 2022; 3():855914. PubMed ID: 37746186
[TBL] [Abstract][Full Text] [Related]
117. COVID-19-Associated Pulmonary Aspergillosis Complicated by Severe Coronavirus Disease: Is Detection of Aspergillus in Airway Specimens Before Disease Onset an Indicator of Antifungal Prophylaxis?
Kitayama T; Tone K; Makimura K; Takagi M; Kuwano K
Cureus; 2023 Mar; 15(3):e36212. PubMed ID: 37069870
[TBL] [Abstract][Full Text] [Related]
118. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N; Pedicone L; Patino H; Durrant S
N Engl J Med; 2007 Jan; 356(4):335-47. PubMed ID: 17251530
[TBL] [Abstract][Full Text] [Related]
119. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
Schauwvlieghe AFAD; Rijnders BJA; Philips N; Verwijs R; Vanderbeke L; Van Tienen C; Lagrou K; Verweij PE; Van de Veerdonk FL; Gommers D; Spronk P; Bergmans DCJJ; Hoedemaekers A; Andrinopoulou ER; van den Berg CHSB; Juffermans NP; Hodiamont CJ; Vonk AG; Depuydt P; Boelens J; Wauters J;
Lancet Respir Med; 2018 Oct; 6(10):782-792. PubMed ID: 30076119
[TBL] [Abstract][Full Text] [Related]
120. A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit.
White PL; Dhillon R; Cordey A; Hughes H; Faggian F; Soni S; Pandey M; Whitaker H; May A; Morgan M; Wise MP; Healy B; Blyth I; Price JS; Vale L; Posso R; Kronda J; Blackwood A; Rafferty H; Moffitt A; Tsitsopoulou A; Gaur S; Holmes T; Backx M
Clin Infect Dis; 2021 Oct; 73(7):e1634-e1644. PubMed ID: 32860682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
